I recently read the fund manager’s from Platinum asset mgmt’s biotech and they said the Virtus LifeSci biotech clinical trials ETF (BBC) was a better indicator than XBI for small biotechs doing clinical trials (as XBI has revenue generating big pharma on it). Just see the correlation to Race and Clarity over the last year. (Blue line is RAC)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.025(2.08%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.17 | $130.6K | 109.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10250 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 2000 | 1 |
View Market Depth
| Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |